Home Merlin Test Menu SARS-CoV-2

SARS-CoV-2

MAVERICK

MAVERICK

SARS-CoV-2 Multi-Antigen Serology Panel V2

Is designed to test for SARS-CoV-2 antibodies as well as other viruses that have similar symptoms but are not COVID-19. Unlike competitive serology tests that only detect antibodies to a limited number of SARS-CoV-2 antigens, the Maverick ™ SARS-CoV-2 Multi-Antigen Serology Panel v2 includes five SARS-CoV-2 antigens and eight other virus antigens. The larger number of antigens tested reduces false positives and negatives. 

 

SARS-CoV-2 Panel Analytes

SARS-COV-2

  • Anti-CoV-2 Nucleocapsid
  • Anti-CoV-2 Spike S1 RBD
  • Anti-CoV-2 Spike S152
  • Anti-CoV-2 Spike S2
  • Anti-CoV-2 Spike S1

INFLUENZA

  • Anti-Influenza H1
  • Anti-Influenza H3

Benign Coronavirus

  • Anti-CoV HKU1 Spike
  • Anti-CoV OC43 Spike
  • Anti-CoV NL63 Nucleoprotein
  • Anti-CoV 229E Spike

MERS

Anti-MERS Spike S1

SARS-COV-1

Anti-CoV-1 Nucleocapsid

Assay Specifications

Antibodies Detected

IgM & IgG

Sensitivity

96.1%

Number of Targets

26

Specificity

97.7%

Time to Result

20 Min

Sample Type

EDTA Whole Blood, Serum, Fingerstick

Result Generation

Overall positive/negative result called with a machine learning algorithm

 

  • Trained on 1200+ patients

  • Validated on 2,700 patients

  • Uses all 26 targets (13 antigens , IgG & IgM)

  • Significant performance improvement over single antigen tests 

AI LEarning

Genalyte outperforms competitors

NorthShore Health System Study: Genalyte is highest performing tests across all competitors

Antibody Test

Samples

197

197

197

197

accuracy

99%

98%

96%

93%

sensitivity

98%

96%

92%

87%

specificity

100%

100%

100%

100%